Govt imposes export curbs on syringes to discourage outbound shipments
New Delhi: The government on Monday announced imposing export curbs on syringes with immediate effect, a move aimed at discouraging outbound shipments of the product in view of the present Covid-19 pandemic situation.The directorate general of foreign trade (DGFT) in a notification said it has moved syringes export in the restricted category, under which an exporter has to seek a licence...
New Delhi: The government on Monday announced imposing export curbs on syringes with immediate effect, a move aimed at discouraging outbound shipments of the product in view of the present Covid-19 pandemic situation.
The directorate general of foreign trade (DGFT) in a notification said it has moved syringes export in the restricted category, under which an exporter has to seek a licence or government permission for the shipments.
"The export of syringes with or without needles...has been put under the restricted category with immediate effect," it said.
In 2020-21, the export of syringes stood at USD 45.68 million. It was USD 17.37 million during April-July this fiscal.
As per the DGFT the procedure for submission and approval of application for export of syringes will be notified separately, reports PTI.
In a separate public notice, the DGFT said the quantity of 5,841 tonnes of sugar (raw and/or white sugar) to be exported to the European Union (EU) under TRQ scheme from October 1, to September 30, 2022 has been notified.
TRQ (Tariff-Rate Quota) is for a volume of exports that enter the UK at relatively low tariffs. After the quota is reached, a higher tariff applies to the exports.
In August, the government had imposed restrictions on export of COVID-19 rapid antigen testing kits amid several experts warning of a possible third wave of the coronavirus pandemic.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd